May 10 |
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
|
May 10 |
Ligand (LGND) Is a Great Choice for 'Trend' Investors, Here's Why
|
May 9 |
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
|
May 9 |
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
|
May 9 |
Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?
|
May 9 |
Ligand Pharmaceuticals First Quarter 2024 Earnings: EPS: US$4.86 (vs US$2.56 in 1Q 2023)
|
May 9 |
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
|
May 8 |
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript
|
May 8 |
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
|
May 8 |
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
|